Onglyza®, new inhibitor of DPP-4, now available and repaid

被引：0
作者：
不详
机构：
来源：
CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION | 2010年 / 14卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：309 / 309
页数：1
相关论文
共 50 条
[21]   Teneligliptin: a DPP-4 inhibitor for the treatment of type 2 diabetes [J].
Kishimoto, Miyako .
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2013, 6 :187-195
[22]   A Scalable Synthesis of an Azabicyclooctanyl Derivative, a Novel DPP-4 Inhibitor [J].
Fei, Zhongbo ;
Wu, Quanbing ;
Zhang, Fei ;
Cao, Yudong ;
Liu, Chuanqin ;
Shieh, Wen-Chung ;
Xue, Song ;
McKenna, Joe ;
Prasad, Kapa ;
Prashad, Mahavir ;
Baeschlin, Daniel ;
Namoto, Kenji .
JOURNAL OF ORGANIC CHEMISTRY, 2008, 73 (22) :9016-9021
[23]   DPP-4 Inhibitor-Related Pancreatitis: Rare but Real! [J].
DeVries, J. Hans ;
Rosenstock, Julio .
DIABETES CARE, 2017, 40 (02) :161-163
[24]   DPP-4 inhibitors [J].
Ahren, Bo .
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 21 (04) :517-533
[25]   DPP-4 inhibitor (sitagliptin)-induced seronegative rheumatoid arthritis [J].
Padron, Simonette ;
Rogers, Everett ;
Beckler, Michelle Demory ;
Kesselman, Marc .
BMJ CASE REPORTS, 2019, 12 (08)
[26]   The safety of DPP-4 inhibitor and SGLT2 inhibitor combination therapies [J].
Molina-Vega, Maria ;
Munoz-Garach, Araceli ;
Fernandez-Garcia, Jose C. ;
Tinahones, Francisco J. .
EXPERT OPINION ON DRUG SAFETY, 2018, 17 (08) :815-824
[27]   Hepatic safety profile of vildagliptin, a new DPP-4 inhibitor for the treatment of type 2 diabetes [J].
Kothny, W. ;
Schweizer, A. ;
Dickinson, S. ;
Ligueros-Saylan, M. .
DIABETOLOGIA, 2009, 52 :S301-S301
[28]   Saxagliptin, a new DPP-4 inhibitor for the treatment of type 2 diabetes mellitus: novel aspects [J].
Pedrianes Martin, P. ;
de Pablos Velasco, P. L. .
AVANCES EN DIABETOLOGIA, 2010, 26 (06) :446-448
[29]   Cardiovascular safety profile of vildagliptin, a new DPP-4 inhibitor for the treatment of type 2 diabetes [J].
Kothny, W. ;
Gimpelewicz, C. R. ;
Byiers, S. ;
Mills, D. ;
Fitchet, M. .
EUROPEAN HEART JOURNAL, 2008, 29 :473-473
[30]   DPP-4 inhibitors in diabetic complications: role of DPP-4 beyond glucose control [J].
Eun Ju Bae .
Archives of Pharmacal Research, 2016, 39 :1114-1128
12345